Troglitazone

Caroline Day*, Clifford J. Bailey

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

Abstract

Troglitazone was the first thiazolidinedione antihyperglycemic agent to be introduced for the treatment of type 2 diabetes mellitus. It was introduced in 1997, but withdrawn almost immediately (UK) or by 2000 (USA) as evidence emerged of fatal idiosyncratic hepatotoxicity... © 2007

Original languageEnglish
Title of host publicationxPharm
Subtitle of host publicationthe comprehensive pharmacology reference
PublisherElsevier
Number of pages3
ISBN (Print)978-0-08-055232-3
DOIs
Publication statusPublished - Feb 2011

Fingerprint

troglitazone
Hypoglycemic Agents
Type 2 Diabetes Mellitus
2,4-thiazolidinedione

Cite this

Day, C., & Bailey, C. J. (2011). Troglitazone. In xPharm: the comprehensive pharmacology reference Elsevier. https://doi.org/10.1016/B978-008055232-3.62812-0
Day, Caroline ; Bailey, Clifford J. / Troglitazone. xPharm: the comprehensive pharmacology reference. Elsevier, 2011.
@inbook{af878b1f8d4b4a5bb37709aa4b96eb76,
title = "Troglitazone",
abstract = "Troglitazone was the first thiazolidinedione antihyperglycemic agent to be introduced for the treatment of type 2 diabetes mellitus. It was introduced in 1997, but withdrawn almost immediately (UK) or by 2000 (USA) as evidence emerged of fatal idiosyncratic hepatotoxicity... {\circledC} 2007",
author = "Caroline Day and Bailey, {Clifford J.}",
year = "2011",
month = "2",
doi = "10.1016/B978-008055232-3.62812-0",
language = "English",
isbn = "978-0-08-055232-3",
booktitle = "xPharm",
publisher = "Elsevier",
address = "Netherlands",

}

Day, C & Bailey, CJ 2011, Troglitazone. in xPharm: the comprehensive pharmacology reference. Elsevier. https://doi.org/10.1016/B978-008055232-3.62812-0

Troglitazone. / Day, Caroline; Bailey, Clifford J.

xPharm: the comprehensive pharmacology reference. Elsevier, 2011.

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

TY - CHAP

T1 - Troglitazone

AU - Day, Caroline

AU - Bailey, Clifford J.

PY - 2011/2

Y1 - 2011/2

N2 - Troglitazone was the first thiazolidinedione antihyperglycemic agent to be introduced for the treatment of type 2 diabetes mellitus. It was introduced in 1997, but withdrawn almost immediately (UK) or by 2000 (USA) as evidence emerged of fatal idiosyncratic hepatotoxicity... © 2007

AB - Troglitazone was the first thiazolidinedione antihyperglycemic agent to be introduced for the treatment of type 2 diabetes mellitus. It was introduced in 1997, but withdrawn almost immediately (UK) or by 2000 (USA) as evidence emerged of fatal idiosyncratic hepatotoxicity... © 2007

UR - http://www.scopus.com/inward/record.url?scp=84884078690&partnerID=8YFLogxK

U2 - 10.1016/B978-008055232-3.62812-0

DO - 10.1016/B978-008055232-3.62812-0

M3 - Chapter (peer-reviewed)

AN - SCOPUS:84884078690

SN - 978-0-08-055232-3

BT - xPharm

PB - Elsevier

ER -

Day C, Bailey CJ. Troglitazone. In xPharm: the comprehensive pharmacology reference. Elsevier. 2011 https://doi.org/10.1016/B978-008055232-3.62812-0